28 Apr DANE DICKSON
[et_pb_section admin_label=”section”][et_pb_row admin_label=”row”][et_pb_column type=”1_4″][et_pb_image admin_label=”Image” src=”http://www.pmwcintl.xyz/wp-content/uploads/2016/04/DANEDICKSON.jpg” show_in_lightbox=”off” url_new_window=”off” use_overlay=”off” animation=”left” sticky=”off” align=”center” force_fullwidth=”off” always_center_on_mobile=”on” use_border_color=”off” border_color=”#ffffff” border_style=”solid”] [/et_pb_image][/et_pb_column][et_pb_column type=”3_4″][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
M.D., DIRECTOR, CLINICAL SCIENCE-MOLDX, PALMETTO GBA
Serving as the MolDX Director of Clinical Science, Dr. Dickson is a board certified medical oncologist. In addition to his work with Palmetto, he also serves as the Director of the Teton Cancer Institute in Southeast Idaho. With over a decade in a full-time clinical practice, Dr. Dickson has served as the President of the Summarius Corporation, which created and implemented an evidence-based method of presenting clinical trial information, as an advisor to two distinct contract medical directors for CMS, serving as a carrier advisory committee member (CAC), as President of the Idaho Society of Clinical Oncology (ISCO), and as a member of the executive subcommittee of the State Affiliate Council of American Society of Clinical Oncology (ASCO). He received his medical degree from the University of Utah, where he graduated with honors. He then received internal medicine training at Washington Universities Barnes-Jewish Hospital. He completed a medical oncology fellowship at the Huntsman Cancer Institute at the University of Utah.